“Finally, the future has something good in store for us. For women who have been enduring years of incredibly painful and interruptive menstrual cycles, the NannoPad should absolutely be on your radar.”
*Names of publications are trademarks of their respective owners, and are in no way affiliates or sponsors of Nannocare or its products.
"The issuer promptly discloses on its website or, for Regulation CF issuers, through an intermediary’s platform, or provides direct notification to its investors, that is is relying on the temporary final rules; the SEC posted a memo to provide both Regulation A+ and Regulation CF issuers interim relief on on-going reporting requirements due to the current COVID-19 pandemic."
Use left/right arrows to navigate the slideshow or swipe left/right if using a mobile device
choosing a selection results in a full page refresh